Diisopropylethylamine → HCID 25099555, compound
Reaction equation
[F:1][C:2]1[CH:3]=[C:4]([C:8]2[N:13]=[C:12]([CH3:14])[C:11]([C:15]([OH:17])=O)=[CH:10][N:9]=2)[CH:5]=[CH:6][CH:7]=1.C1CN([P+](ON2N=NC3C=CC=NC2=3)(N2CCCC2)N2CCCC2)CC1.F[P-](F)(F)(F)(F)F.CCN(C(C)C)C(C)C.[Br:60][C:61]1[CH:62]=[C:63]2[C:67](=[CH:68][CH:69]=1)[N:66]([NH2:70])[CH:65]=[CH:64]2>C(Cl)Cl.O.CCOC(C)=O>[Br:60][C:61]1[CH:62]=[C:63]2[C:67](=[CH:68][CH:69]=1)[N:66]([NH:70][C:15]([C:11]1[C:12]([CH3:14])=[N:13][C:8]([C:4]3[CH:5]=[CH:6][CH:7]=[C:2]([F:1])[CH:3]=3)=[N:9][CH:10]=1)=[O:17])[CH:65]=[CH:64]2Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 3
Procedure
A solution of 2-(3-fluoro-phenyl)-4-methyl-pyrimidine-5-carboxylic acid (596 mg, 2.57 mmol), PyAOP (2.63 mmol), and DIPEA (830 μL, 4.75 mmol) in DCM (20 mL) is stirred at rt under N2 for 10 min. 5-Bromoindol-1-ylamine (500 mg, 2.37 mmol) is added. The resulting mixture is stirred at rt overnight. The mixture is portioned between EtOAc and water. The organic phase is separated, washed with saturated aqueous NaHCO3, water and brine, dried (MgSO4), filtered and concentrated in vacuo. The residue is purified by silica gel chromatography eluting with 2% MeOH in DCM to afford 2-(3-fluoro-phenyl)-4-methyl-pyrimidine-5-carboxylic acid (5-bromo-indol-1-yl)-amide (246 mg, 24%) as a solid. MS: 425 (M) & 427 (M+2). 1H NMR (300 MHz, DMSO-d6): δ 12.02 (s, 1H), 9.24 (s, 1H), 8.34 (d, 1H), 8.20-8.15 (m, 1H), 7.84 (d, 1H), 7.68-7.61 (m, 1H), 7.59 (d, 1H), 7.50-7.43 (m, 2H), 7.35 (dd, 1H), 6.57 (dd, 1H), 2.78 (s, 3H).
Workup
- customThe organic phase is separated
- washwashed with saturated aqueous NaHCO3, water and brine
- dry with materialdried (MgSO4)
- filtrationfiltered
- concentrationconcentrated in vacuo
- customThe residue is purified by silica gel chromatography
- washeluting with 2% MeOH in DCM
Sources & evidence
- ORD record
- ord-e8ca09b0e2654ee1b83793de40624ed4
- Source dataset
- uspto-grants-2012_09
- Patent number
- US08258130B2
Reaction notes
Loading…